333 related articles for article (PubMed ID: 32865982)
21. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
22. Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1.
Krabill AD; Chen H; Hussain S; Hewitt CS; Imhoff RD; Muli CS; Das C; Galardy PJ; Wendt MK; Flaherty DP
Molecules; 2021 Feb; 26(5):. PubMed ID: 33668938
[TBL] [Abstract][Full Text] [Related]
23. Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
Zhang W; Bailey-Elkin BA; Knaap RCM; Khare B; Dalebout TJ; Johnson GG; van Kasteren PB; McLeish NJ; Gu J; He W; Kikkert M; Mark BL; Sidhu SS
PLoS Pathog; 2017 May; 13(5):e1006372. PubMed ID: 28542609
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson's Disease.
Buneeva O; Medvedev A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279302
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide analysis of genes encoding core components of the ubiquitin system during cerebral cortex development.
Bouron A; Fauvarque MO
Mol Brain; 2022 Aug; 15(1):72. PubMed ID: 35974412
[TBL] [Abstract][Full Text] [Related]
26. K27-Linked Diubiquitin Inhibits UCHL3 via an Unusual Kinetic Trap.
van Tilburg GBA; Murachelli AG; Fish A; van der Heden van Noort GJ; Ovaa H; Sixma TK
Cell Chem Biol; 2021 Feb; 28(2):191-201.e8. PubMed ID: 33238157
[TBL] [Abstract][Full Text] [Related]
27. Design and Synthesis of Ubiquitin-Based Chemical Tools with Unnatural Amino Acids for Selective Detection of Deubiquitinases.
Rut W; Zmudzinski M; Drag M
Methods Mol Biol; 2023; 2591():59-78. PubMed ID: 36350543
[TBL] [Abstract][Full Text] [Related]
28. Positional-scanning fluorigenic substrate libraries reveal unexpected specificity determinants of DUBs (deubiquitinating enzymes).
Drag M; Mikolajczyk J; Bekes M; Reyes-Turcu FE; Ellman JA; Wilkinson KD; Salvesen GS
Biochem J; 2008 Nov; 415(3):367-75. PubMed ID: 18601651
[TBL] [Abstract][Full Text] [Related]
29. The new function of two ubiquitin C-terminal hydrolase isozymes as reciprocal modulators of germ cell apoptosis.
Kwon J
Exp Anim; 2007 Apr; 56(2):71-7. PubMed ID: 17460351
[TBL] [Abstract][Full Text] [Related]
30. The emerging role of deubiquitination in nucleotide excision repair.
Zhang L; Gong F
DNA Repair (Amst); 2016 Aug; 44():118-122. PubMed ID: 27316462
[TBL] [Abstract][Full Text] [Related]
31. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.
Bilguvar K; Tyagi NK; Ozkara C; Tuysuz B; Bakircioglu M; Choi M; Delil S; Caglayan AO; Baranoski JF; Erturk O; Yalcinkaya C; Karacorlu M; Dincer A; Johnson MH; Mane S; Chandra SS; Louvi A; Boggon TJ; Lifton RP; Horwich AL; Gunel M
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3489-94. PubMed ID: 23359680
[TBL] [Abstract][Full Text] [Related]
32. The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK).
Davies CW; Chaney J; Korbel G; Ringe D; Petsko GA; Ploegh H; Das C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3900-4. PubMed ID: 22617491
[TBL] [Abstract][Full Text] [Related]
33. Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response.
Snyder NA; Silva GM
J Biol Chem; 2021 Sep; 297(3):101077. PubMed ID: 34391779
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration.
Sharma A; Liu H; Tobar-Tosse F; Chand Dakal T; Ludwig M; Holz FG; Loeffler KU; Wüllner U; Herwig-Carl MC
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486284
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor.
Krabill AD; Chen H; Hussain S; Feng C; Abdullah A; Das C; Aryal UK; Post CB; Wendt MK; Galardy PJ; Flaherty DP
Chembiochem; 2020 Mar; 21(5):712-722. PubMed ID: 31449350
[TBL] [Abstract][Full Text] [Related]
36. Friend or Foe: UCHL3 Mediated Carcinogenesis and Current Approaches in Small Molecule Inhibitors' Development.
Samy MA; Abd El Fatah NM; Yahia SE; Arafa RK
Curr Med Chem; 2021; 28(42):8782-8799. PubMed ID: 34238144
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
38. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
Kumar P; Kumar P; Mandal D; Velayutham R
Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
[TBL] [Abstract][Full Text] [Related]
39. Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury.
Mi Z; Graham SH
Ageing Res Rev; 2023 Apr; 86():101856. PubMed ID: 36681249
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease.
Wilson CL; Murphy LB; Leslie J; Kendrick S; French J; Fox CR; Sheerin NS; Fisher A; Robinson JH; Tiniakos DG; Gray DA; Oakley F; Mann DA
J Hepatol; 2015 Dec; 63(6):1421-8. PubMed ID: 26264933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
